J3397 Injection., vestronidase alfa-vjbk
J-Codes
Also known as: vestronidase alfa, Mepsevii, lysosomal enzyme
Vestronidase alfa-vjbk (Mepsevii) injection is a recombinant lysosomal enzyme for sialidosis and galactosialidosis treatment.
Clinical Context
Enzyme replacement therapy for sialidosis and galactosialidosis. Recombinant sialidase administered intravenously. Reduces accumulation of sialylated glycoproteins in lysosomal storage diseases.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.